Status:
COMPLETED
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
Lead Sponsor:
Institut de Myologie, France
Collaborating Sponsors:
Association Française contre les Myopathies (AFM), Paris
Conditions:
Autoimmune Myasthenia Gravis
Lambert-Eaton Myasthenic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
A few recent observational studies show that despite the lack of clear recommendations, many individuals with myasthenia participate in exercise. However, no link has been found between exercise and t...
Eligibility Criteria
Inclusion
- at least 18 years old
- confirmed diagnosis of MG or SMC or LEMS
- Live in France or its territories
- Provide consent
Exclusion
- \-
Key Trial Info
Start Date :
November 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05408702
Start Date
November 12 2021
End Date
May 15 2022
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Online Questionnaire
Paris, France